Millipore and Rohm and Haas entered into a joint development agreement to create high-performance chromatography products that are used to manufacture biologic drugs.Millipore will gain exclusive access to new, customized chromatography media developed under the agreement.
The companies say the strength of the partnership lies in combining Millipore’s biopharmaceutical manufacturing expertise with Rohm and Haas’ knowledge of ion exchange resins, polymer chemistry, and manufacturing.
